Literature DB >> 26550050

Software-Based Hybrid Perfusion SPECT/CT Provides Diagnostic Accuracy When Other Pulmonary Embolism Imaging Is Indeterminate.

Nishant Kumar1, Karen Xie1, Winnie Mar1, Thomas M Anderson1, Benjamin Carney1, Nikhil Mehta1, Roberto Machado2, Michael J Blend1, Yang Lu1.   

Abstract

PURPOSE: To investigate the diagnostic performance of perfusion single-photon emission computed tomography/computed tomography (Q-SPECT/CT) in patients suspected to have pulmonary embolism (PE) but with indeterminate computed tomographic pulmonary angiography (CTPA) or planar ventilation/perfusion (V/Q) scans.
METHODS: This retrospective study included two groups of patients. Group I consisted of 49 patients with nondiagnostic CTPA. These 49 patients underwent subsequent V/Q scans. Further Q-SPECTs were obtained in patients with indeterminate planar images and fused with existing CTPA. Group II consisted of 182 non-CTPA patients with indeterminate V/Q scans. These 182 patients underwent further Q-SPECT and separate noncontrast low-dose CT chest. Fusion Q-SPECT/CT scans were obtained through FDA-approved software and interpreted according to published criteria as positive, negative, or indeterminate for PE. Upon retrospective analyses, the final diagnosis was made using composite reference standards including all available clinical and imaging information for at least 6-month follow-up.
RESULTS: In group I patients, 1 was positive, 24 were negative, and another 24 (49 %, 24/49) were indeterminate. In the subsequent 24 Q-SPECT/CTPAs, 4 were positive, 19 were negative, and 1 was indeterminate (4.2 %, 1/24). In group II patients, 9 (4.9 %, 9/182) were indeterminate, 33 were positive, and 140 were negative. The combined nondiagnostic rate for Q-SPECT/CT was only 4.9 % (10/206). There was six false-negative and one false-positive Q-SPECT/CT examinations. The sensitivity, specificity, and positive and negative predictive value of Q-SPECT/CT were 85.7 % (36/42), 99.4 % (153/154), 97.3 % (36/37) and 96.2 % (153/159), respectively.
CONCLUSIONS: Q-SPECT/CT improves the diagnostic rate with promising accuracy in diagnosing PE that yields a satisfactory clinical verdict, especially when the CTPA and planar V/Q scan are indeterminate.

Entities:  

Keywords:  CTPA; Pulmonary Embolism; Q-SPECT/CT; V/Q

Year:  2015        PMID: 26550050      PMCID: PMC4630324          DOI: 10.1007/s13139-015-0359-8

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  32 in total

1.  Acute pulmonary embolism detected by perfusion SPECT/CT masquerading as an intermediate probability planar V/Q scan.

Authors:  Yang Lu; Josef J Fox
Journal:  Clin Nucl Med       Date:  2010-12       Impact factor: 7.794

Review 2.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

Review 3.  Challenges, controversies, and hot topics in pulmonary embolism imaging.

Authors:  Gelareh Sadigh; Aine Marie Kelly; Paul Cronin
Journal:  AJR Am J Roentgenol       Date:  2011-03       Impact factor: 3.959

4.  The scintigraphic definition of pulmonary embolism.

Authors:  B J McNeil; B L Holman; S J Adelstein
Journal:  JAMA       Date:  1974-02-18       Impact factor: 56.272

5.  Time trends in pulmonary embolism in the United States: evidence of overdiagnosis.

Authors:  Renda Soylemez Wiener; Lisa M Schwartz; Steven Woloshin
Journal:  Arch Intern Med       Date:  2011-05-09

6.  Pulmonary embolism: prospective comparison of spiral CT with ventilation-perfusion scintigraphy.

Authors:  J R Mayo; M Remy-Jardin; N L Müller; J Remy; D F Worsley; C Hossein-Foucher; J S Kwong; M J Brown
Journal:  Radiology       Date:  1997-11       Impact factor: 11.105

7.  Diagnosis of pulmonary embolus using ventilation/perfusion lung scintigraphy: more than 0.5 segment of ventilation/perfusion mismatch is sufficient.

Authors:  D M Howarth; J A Booker; D D Voutnis
Journal:  Intern Med J       Date:  2006-05       Impact factor: 2.048

8.  Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry.

Authors:  Silvy Laporte; Patrick Mismetti; Hervé Décousus; Fernando Uresandi; Remedios Otero; Jose Luis Lobo; Manuel Monreal
Journal:  Circulation       Date:  2008-03-17       Impact factor: 29.690

9.  Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample.

Authors:  Brian Park; Louis Messina; Phong Dargon; Wei Huang; Rocco Ciocca; Frederick A Anderson
Journal:  Chest       Date:  2009-06-12       Impact factor: 9.410

10.  CT pulmonary angiography: increasingly diagnosing less severe pulmonary emboli.

Authors:  Andrew J Schissler; Anna Rozenshtein; Michal E Kulon; Gregory D N Pearson; Robert A Green; Peter D Stetson; David J Brenner; Belinda D'Souza; Wei-Yann Tsai; Neil W Schluger; Andrew J Einstein
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

View more
  4 in total

1.  Quantitative single-photon emission computed tomography/computed tomography for technetium pertechnetate thyroid uptake measurement.

Authors:  Hyunjong Lee; Ji Hyun Kim; Yeon-Koo Kang; Jae Hoon Moon; Young So; Won Woo Lee
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

2.  The Economic Value of Hybrid Single-photon Emission Computed Tomography With Computed Tomography Imaging in Pulmonary Embolism Diagnosis.

Authors:  Lauren K Toney; Richard D Kim; Swetha R Palli
Journal:  Acad Emerg Med       Date:  2017-08-14       Impact factor: 3.451

3.  Perfusion SPECT/CT to diagnose pulmonary embolism during COVID-19 pandemic.

Authors:  Yang Lu; Homer A Macapinlac
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-08       Impact factor: 9.236

4.  Comparison between CT and MRI in the assessment of pulmonary embolism: A meta-analysis.

Authors:  Feng Chen; Yi-Hong Shen; Xu-Qing Zhu; Jing Zheng; Feng-Jie Wu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.